Chemotherapy

Chemotherapy is the use of medicines that interfere with the way cancer cells grow and divide. Because cancer cells divide much faster than most healthy cells, they are especially vulnerable to these drugs, which is why a well-designed regimen can shrink or control a tumour while normal tissues largely recover. Different drug families act at different points in the life cycle of a cell, so two or more agents are often combined to attack the cancer from several directions at once. Chemotherapy travels through the bloodstream and reaches cells all over the body, which is what makes it suitable for cancers that may have spread beyond their starting point. It can be the main treatment, or it can be used before surgery to shrink a tumour, after surgery to clear any cells left behind, or alongside radiotherapy to make both more effective.

Chemotherapy is recommended whenever a cancer is best controlled by a treatment that works throughout the whole body rather than in one spot. This includes cancers of the breast, lung, bowel, stomach, ovary and prostate, as well as blood cancers such as lymphoma and leukaemia, among many others. The intent varies: sometimes the aim is cure, sometimes it is to lower the chance of the cancer returning after surgery, and sometimes it is to control the disease and ease symptoms when cure is not possible. The decision is made by a multidisciplinary team that reviews the tumour type, its stage, its molecular profile and the patient's general health, so that the regimen is matched to the individual rather than applied as a one-size-fits-all treatment. For many cancers, chemotherapy is combined with surgery, radiotherapy, targeted drugs or immunotherapy in a planned sequence.

Most chemotherapy is given by a drip into a vein, usually through a small device called a port that is placed under the skin to protect the veins over a long course. Some regimens are taken as tablets at home on a set schedule, with regular clinic checks, and a few are placed directly into a body cavity such as the abdomen or bladder. A single infusion day typically lasts a few hours and is given in a comfortable day unit, after which the patient goes home; only the more intensive or high-dose regimens, including those followed by a stem cell transplant for some blood cancers, require admission to hospital. Treatment is organised into cycles, often every one to four weeks, with a built-in recovery gap so that healthy tissues can bounce back before the next dose. Before each cycle, blood counts and kidney and liver function are checked to confirm it is safe to proceed, and the dose can be adjusted to keep treatment both effective and tolerable.

Almost anyone with a cancer that responds to drug treatment can be considered, but the regimen is tailored to fitness, organ function and other medical conditions, and gentler schedules are available for older or frailer patients. Preparation begins with confirming the diagnosis and stage through a biopsy and imaging, followed by blood tests, heart and kidney checks and a dental review when relevant, since these establish a safe baseline. A small port may be placed before the first cycle to make repeated infusions easier. Patients are counselled in advance about likely side effects, fertility preservation where it applies, and the practical rhythm of the cycles. For international patients, much of this groundwork can begin remotely: scans, pathology slides and reports can be reviewed before travel, so that the plan is largely agreed before arrival and the in-person assessment confirms it and starts treatment without delay.

There is no single recovery in the surgical sense; instead, each cycle brings a few days when tiredness, nausea or a dip in blood counts are most noticeable, followed by a gradual return toward normal before the next one. Because a full course can run for weeks or months, the key planning question is how much to do abroad. A common and practical approach is to complete the diagnostic work-up, the treatment plan and the first cycles under expert supervision in the destination city, then continue the remaining cycles closer to home under a clear written protocol shared with the home oncologist. Some patients prefer to stay for the whole course; others travel back and forth between cycles. Whichever route is chosen, the destination team provides a detailed plan covering drugs, doses, schedule and monitoring, so that later cycles and blood tests can be carried out safely by a doctor near home, with the original team reachable for advice. International patient offices commonly arrange interpreters, accommodation near the day unit and coordination of the travel timetable around the cycles.

Chemotherapy is a powerful and well-established treatment, and modern supportive care has made it far more tolerable than in the past, though it still carries side effects because it also affects some healthy fast-dividing cells. Common, temporary effects include nausea, tiredness, mouth soreness, hair thinning or loss, and a drop in blood counts that raises the risk of infection, anaemia or bruising; these are actively managed with anti-sickness drugs, growth factors, transfusions and careful monitoring. A small number of agents carry a risk of longer-term effects such as nerve tingling in the hands and feet, effects on the heart, or, rarely, a second cancer years later; the specific risk profile depends on the exact drugs and the total dose. Response is checked at planned intervals with scans, and where useful with tumour markers, so the plan can be intensified, eased or changed if needed. Choosing an experienced team, following the monitoring schedule and keeping home and destination doctors in close contact are the keys to a safe course and the best possible result.